✦ LIBER ✦

A double-blind controlled trial on the efficacy and safety of a new synthetic HMG-CoA reductase inhibitor, fluvastatin, with and without open-label niacin, in the treatment of hypercholesterolemia

✍ Scribed by Terry A. Jacobson; Margaret Chin; Gregg Fromell; Louis F. Amorosa; Leonard A. Jokubaitis

Book ID: 118324667
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 159 KB
Volume: 108
Category: Article
ISSN: 0021-9150
DOI: 10.1016/0021-9150(94)90178-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of a new HMG-CoA red

Efficacy and safety of a new HMG-CoA reductase inhibitor, NK-104, in patients with hypertriglyceridemia — Randomized double-blind, cross-over placebo controlled study

✍ J Sasaki; Y Ikeda; K Yamamoto; M Ageta; K Arakawa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 134 KB

A Double-Blind, Randomized, Saline-Contr

A Double-Blind, Randomized, Saline-Controlled Study of the Efficacy and Safety of EUFLEXXA® for Treatment of Painful Osteoarthritis of the Knee, With an Open-Label Safety Extension (The FLEXX Trial)

✍ Roy D. Altman; Jeffrey E. Rosen; Daniel A. Bloch; Hind T. Hatoum; Paul Korner 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 534 KB

Efficacy of adalimumab in the treatment

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two

✍ Hildrun Haibel; Martin Rudwaleit; Joachim Listing; Frank Heldmann; Robert L. Won 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 3 views

Design and Rationale of the LAPLACE-TIMI

Design and Rationale of the LAPLACE-TIMI 57 Trial: A Phase II, Double-Blind, Placebo-Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 in Subjects With Hypercholesterolemia on Background Statin Therapy

✍ Payal Kohli; Nihar R. Desai; Robert P. Giugliano; Jae B. Kim; Ransi Somaratne; F 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

✍ M. A. Nauck; G. Meininger; D. Sheng; L. Terranella; P. P. Stein; Sitagliptin Stu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

A prospective, double-blind, randomized,

A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

✍ Bin Nie; Wan-Jun Cheng; Yan-Fang Li; Zheng Cao; Qing Yang; Ying-Xin Zhao; Yong-H 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views